By USA TODAY
Pfizer plans to complete two more studies of its antiviral therapy, Paxlovid, by the end of the year. Latest COVID-19 updates.
Source:: Top National News
By USA TODAY
Pfizer plans to complete two more studies of its antiviral therapy, Paxlovid, by the end of the year. Latest COVID-19 updates.
Source:: Top National News